JNSF PHARMA LIMITED
UNIT-2, CENTRAL SQUARE SHOPPING CENTRE HIGH STREET, ERDINGTON, BIRMINGHAM  B23 6RY- Active
- Private Limited Company
- Company No. 14414547
- Last Updated: 01 Mar 2024
Company Profile
JNSF PHARMA LIMITED was incorporated on Wednesday, October 12, 2022 as a Private Limited Company with registered address in BIRMINGHAM. JNSF PHARMA LIMITED has the status: Active and it's listed in the following category: Wholesale of pharmaceutical goods. This Private Limited Company has been operating for 2 years 1 month and 3 days.
Name | JNSF PHARMA LIMITED |
---|---|
Company number | 14414547 |
Company type | Private Limited Company |
Incorporation date | 12 Oct 2022 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
UNIT-2, CENTRAL SQUARE SHOPPING CENTRE HIGH STREET ERDINGTON BIRMINGHAM B23 6RY |
---|---|
Country Of Origin | ENGLAND |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mr Niju Cheriyan Nationality: Indian |
Dates: Wednesday, October 12, 2022 - present
ownership of shares 25 to 50 percent
|
Mr Sony Mathew Nationality: British |
Dates: Wednesday, October 12, 2022 - present
ownership of shares 25 to 50 percent
|
Sajida Raza Nationality: Tanzanian |
Dates: Wednesday, October 12, 2022 - present
ownership of shares 25 to 50 percent
|
Mr Jaison Thomas Kappikkara Nationality: British |
Dates: Wednesday, October 12, 2022 - present
ownership of shares 25 to 50 percent
|
Accounts and Confirmation
Type of accounts | NO ACCOUNTS FILED |
---|---|
End of financial Year | 31 October |
Next annual accounts due | 12 July 2024, (-126 days left) |
Latest accounts | Not available |
Next confirmation statement due | 09 November 2023 |
Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against JNSF PHARMA LIMITED.
Previous Names
Name | Change Date |
---|---|
JNSF PHARMA LIMITED | 12 Oct 2022 |